|Articles|May 4, 2021

Brazilian COVID-19 Variant Found to be More Transmissible

Author(s)Killian Meara

The novel variant was found to be 1.7 to 2.4 times more transmissible and can evade 10% to 46% of gained immunity.

A recent study conducted by investigators from Brazil, the United Kingdom and the University of Copenhagen has found that the COVID-19 variant P.1, which originated in Brazil, is more transmissible than the original virus and is able to evade immunity.

Results from the study were published in the journal Science.

The city of Manaus is currently experiencing a deadly second wave of the pandemic, and many investigators believe that the novel variant is the driving force behind it.

“Our main explanation is that there is an aggressive variant of the coronavirus called P.1 which seems be the cause of their problems,” Samir Bhatt, a corresponding author on the study said. “Our epidemiological model indicates that P.1 is likely to be more transmissible than previous strains of coronavirus and likely to be able to evade immunity gained from infection with other strains.”

For the study, the team of investigators employed many different forms of data from the city, including 184 samples of genetic sequencing data and mortality counts, in order to characterize the P.1 variant and its properties.

They then used an epidemiological model to estimate just how transmissible the variant was, and also estimated how it could evade immunity gained from a previous COVID-19 infection.

Findings from the study demonstrated that the P.1 variant is likely to be between 1.7 and 2.4 times more transmissible that other lineages of the virus. They also determined that P.1 is able to evade 10% to 46% of immunity gained from a previous infection.

“As researchers, we have to caution extrapolating these results to be applicable anywhere else in the world,” Bhatt said. “However, our results do underline the fact that more surveillance of the infections and of the different strains of the virus is needed in many countries in order to get the pandemic fully under control.”


Related to this article

FAQ: Ebola Prevention, Treatment and the Chances of a US Outbreak
As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.
FAQ: What You Need to Know About West Nile Virus in 2026
After 2 adults died of West Nile virus in central North Carolina this month, this FAQ explains how the mosquito-borne virus spreads, who faces the greatest risk of severe neuroinvasive disease, and how clinicians can diagnose, manage, and help prevent infection when no vaccine or antiviral treatment exists.